Introduction : Specialized early intervention programs such as The Danish OPUS treatment are efficient in treating patients with a first episode of psychosis (FEP) at least after 2 and 5 years. Few studies have examined long-term outcomes of these interventions. Aim : To examine the effect of 2 years of OPUS vs treatment as usual (TAU) within an FEP cohort, 10 years after inclusion into the OPUS trial. Methods : From 1998 to 2000, participants were randomized to OPUS or TAU. Ten years later, we conducted comprehensive interviews and performed register-based follow-up on all participants in national Danish registers. We analyzed participants according to the intention-to-treat principle. Results : Of the 547 participants included in the study, 347 (63.4%) took part in this follow-up. While there was evidence of a differential 10-year course in the development of negative symptoms, psychiatric bed days, and possibly psychotic symptoms in favor of OPUS treatment, differences were driven by effects at earlier follow-ups and had diminished over time. Statistically significant differences in the course of use of supported housing were present even after 8-10 years. There were no differences between OPUS and TAU regarding income, work-related outcomes, or marital status. Conclusion: Most of the positive short-term effects of the OPUS intervention had diminished or vanished at this long-term follow-up. We observed a clear tendency that OPUS treatment leads to fewer days in supported housing. There is a need for further studies investigating if extending the intervention will improve outcomes more markedly at long-term follow-ups.
Introduction
Psychotic disorders in the schizophrenia spectrum are serious illnesses with potentially devastating consequences for patients and their families and high costs for society. Based on a Danish register-based study, we estimated the incidence rate of schizophrenia among 15-to 34-year-olds to be approximately 37 per 100 000 person-years. 1 The direct cost of schizophrenia sums up to about 2% of the national health expenditure in several European countries. 2 This cost is similar to that of cancer or ischemic heart disease. The reasons for this substantial cost are that schizophrenia has a typical onset in early adult life and while some people will recover, many will experience persisting difficulties or remain vulnerable to future episodes. 3, 4 The positive effects of Assertive Community Treatment (ACT), 5 psychoeducational family intervention, [6] [7] [8] and social skills training 9, 10 for chronic patient populations with psychosis are well documented-as long as the treatment is active. However, the studies which have followed the patients over longer periods of time indicate that some of the effects disappear when the treatment ends. 11, 12 It has been suggested that the long-term course of illness can be influenced during a critical period of 5 years after the onset of the illness. 13 This has led to a wave of early intervention services in Canada, Australia, and in Europe.
The OPUS trial was the first and to date largest randomized clinical trial of a specialized assertive early intervention program (OPUS treatment) vs treatment as usual (TAU, Community Mental Health Centers) for young people experiencing their first episode of nonaffective psychosis (FEP). 14 The intensive early intervention program consisted of modified ACT, psychoeducational family intervention, and social skills training. The treatment lasted for 2 years. Comprehensive follow-up interviews were conducted 1, 2, and 5 years after randomization. After 1 and 2 years of intervention, the OPUS treatment produced significant positive effects on primary outcome measures-psychotic symptoms (hallucinations, delusions, and thought disorders) and negative symptoms (anhedonia, avolition, affective blunting, and alogia)-and on secondary such as substance abuse, treatment adherence, lower dosage of antipsychotic medication, higher satisfaction with treatment, and reduced burden to the family. [15] [16] [17] A recent meta-analysis confirmed that such effects were present across trials in several countries. 18 However, many of these positive effects were not observed in the 5-year follow-up of the OPUS trial, 3 years after the experimental treatment ended. Nevertheless, after 5 years, significantly more patients who received OPUS treatment were able to live independently (as opposed to living in an institution for mentally ill). 11 A similar pattern was found in the 5-year follow-up study of the Lambeth Early Onset trial. 12 
Aim
To examine the effect of intensive early intervention compared to TAU within a cohort with a FEP, 10 years after inclusion into the trial.
Methods

Participants
From March 1998 to December 2000, participants were recruited from all inpatient and outpatient psychiatric treatment sites in Copenhagen and Aarhus (Denmark). Following assessment of inclusion criteria and explanation of the trial protocol both in writing and verbally, 547 participants who were able and willing to provide informed consent were included. This constituted 63% of the eligible patients in Copenhagen and 90% in Aarhus. 16 Inclusion criteria were: 18-45 years of age, recent first diagnosis within the schizophrenic spectrum (F2X.X in ICD-10), and at most 12 consecutive weeks of antipsychotic medication. In the 10-year follow-up study reported here, we interviewed 68% of the participants who were alive and lived in Denmark.
Interventions
Participants were randomized to either TAU (indefinitely) or 2 years of experimental treatment (OPUS treatment) followed by TAU (indefinitely).
The OPUS Treatment. Two new treatment units (one in Copenhagen and one in Aarhus) were established and staff trained before the start of the intervention. The main focus of the OPUS intervention was ACT. In addition to this, patients and their next of kin were encouraged to participate in multifamily groups or to be otherwise involved in the treatment, eg, in psychoeducation meetings. When appropriate, participants were offered social skills training. Cognitive behavior therapy was offered, but only when both relevant and available, since resources were limited. Full details regarding the intervention have been published previously. 14, 16, 19 ACT Each patient was assigned a case manager who was responsible for maintaining contact with the patient and for coordinating the treatment with the rest of the OPUS team, social services, and other involved institutions. The contents of the ACT were modified to more directly target patients experiencing a FEP. The case manager constructed an individually tailored treatment schedule. Consultations took place at either the treatment center or in the patients' homes depending on the preference of each patient and the assessments of the staff. In cases where participants were reluctant to receive treatment, the case manager would try to stay in contact with the patient and attempt to establish a common treatment goal. Caseload was 10:1. The team of case managers consisted of social workers, psychologists, psychiatric nurses, occupational therapists, and a psychiatrist.
Multiple family groups as defined by the McFarlane manual were available. Patients were offered 1.5-hour sessions every second week for 18 months, 6 ,20 treatment elements were illness management and problem solving, and the groups consisted of 4-6 patients with families and 2 therapists simultaneously present.
Social skills training included conversation skills, problem solving, and coping with symptoms and medicine.
TAU. TAU was provided by a community mental health center. The patient was treated through monthly meeting with a psychiatric nurse and with access to consult a social worker. Medication was handled by a psychiatrist. The caseload varied, but was approximately 25:1. Home visits were possible, but office visits were the general rule. Patients were instructed to consult psychiatric emergency departments outside of regular office hours. Elements such as counseling, psychoeducation, and family contact were relatively infrequent compared to that delivered in the OPUS treatment, and not a systematic part of TAU. For more details, see Petersen et al. 16 Antipsychotic Medication. Patients in both treatment groups were offered antipsychotic drugs according to guidelines from the Danish Psychiatric Society, which recommend a low-dose strategy for patients with a first episode of psychotic illness and the use of second-generation antipsychotic drugs as a first choice.
Standardization and Fidelity of the Interventions.
Fidelity to the ACT model was measured to 70% in Copenhagen and Aarhus, evaluated by The Index of Fidelity of Assertive Community Treatment (IFACT) scale. 21 A score of 100% would have required the OPUS intervention to be indefinite, rather than time limited (2 y) and more than 4 weekly patient contacts. The other criteria were met.
Outcomes
We preferably interviewed participants at research facilities in Copenhagen and Aarhus, but also in the patients' own homes, in psychiatric hospitals, supported housing facilities, or wherever the patients requested.
Raters were systematically trained in the use of the outcome measures, and group ratings were conducted with the Scale for the Assessment of Positive Symptoms (SAPS) and Scale for the Assessment of Negative Symptoms (SANS) throughout the assessment period. 22, 23 The intraclass correlation coefficient (ICC) among raters on SAPS ranged from 0.77 to 0.92, corresponding to good agreement. The ICC on SANS ranged from 0.54 to 0.90, corresponding to good to very good agreement. 24 The SAPS and SANS were summarized into a psychotic dimension (the mean of the 4 global SAPS scores), a negative dimension (the mean of the 5 global SANS scores), and a disorganized dimension. Other outcome measures included the Global Assessment of Functioning (GAF), 25 substance abuse, suicidal ideation, antipsychotic drug use, psychiatric treatment, living conditions, vocational and educational status, illness-related absentee days from work, early retirement, homelessness, and income. Income was first standardized to year 2000 values, and then converted to euros by dividing the figure in kroner by 7.4631 (the exchange rate between kroner and euro on January 1, 2000). Information on psychiatric treatment was available from the Psychiatric Central Research register. 26 Information on living conditions, work, education, income, etc. was available from Statistics Denmark and Civil Registration System.
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Sample Size
Sample size calculations were not based on 10-year outcomes. Sample size was estimated based on a difference of 0.5 on the SAPS with a pooled SD of 1.3, which with a power of 90% and alpha of .05 would require 142 participants in each group. Allowing for attrition and subgroup analyses, 547 participants were eventually included. With this sample size, we have 90% power to detect a Cohen's d of 0.28 on continuous outcome measures, given an alpha of .05. Since we use statistically appropriate methods for handling missing data, this also reflects our power to detect differences in the present investigation.
Randomization and Blinding
Centralized 1:1 randomization with concealed treatment allocation was performed, stratified by recruitment center. Due to the nature of the intervention, neither treatment staff nor participants were blind to the allocation. Outcome assessors at the 5-and 10-year follow-ups were kept blind to the treatment allocation, and participants were instructed not to reveal information that would unblind the assessors.
Statistical Methods
Primary Outcome Measures : SAPS, SANS, and GAF. All analyses were done according to the intention-to-treat principle. Data were analyzed in a linear mixed model with repeated measures (utilizing data from baseline and the 1-, 2-, 5-, and 10-y follow-ups), which adequately accounts for missing data under the missing at random assumption. The models included intervention type, time after baseline (as a categorical variable), treatment center, baseline values of the analyzed outcome measure, age, as well as baseline GAF Function and GAF Symptom values, and substance abuse diagnosis (variables which, at one or more interviews, predicted attrition). We included 2-way interaction terms between time and intervention and between time and center. The interaction term between time and intervention indicates whether the development over time of a given outcome differed between the 2 groups, and individual time-point analyses indicate the times at which the outcomes differed significantly, displayed as estimated mean differences from the linear mixed models.
Supported Housing, Homeless Shelters, and Psychiatric Bed
Days. All analyses were done according to the intention-to-treat principle. These analyses were adjusted for center. Because information was obtained from complete nationwide registers, containing information on all original participants, analyses did not have to account for attrition and further adjustment was thus not necessary. Analyses were conducted using linear regression and binomial logistic regression, as appropriate. The distribution of individual number of days per year on all these variables was bimodal in 0 and 365. Since these data are neither normally nor Poisson distributed, the analyses are conducted by means of permutation tests for P values with bootstrap confidence limits.
Suicidal Ideation and Antipsychotic Medication. These analyses were also done according to the intention-totreat principle, using multiple imputations (m = 100) to account for missing data. Imputations were based on information regarding diagnosis, treatment center, age, and sex.
Results
The participant flow through the trial is depicted in figure 1 . Table 1 shows baseline characteristics of all 547 participants included in the trial, with no evidence of baseline imbalances. 11 A total of 347 people (63.4%) participated in the 10-year follow-up assessment. There was no difference in the tendency to participate in the interviews 10 years after the intervention, depending on intervention group. About 70.4% of the OPUS and 66.4% of the TAU patients still alive and living in Denmark participated in the 10-year follow-up study (P = .33). Nonparticipants had poorer functioning than participants on baseline GAF (P = .02 for GAF symptoms and P = .004 for GAF function), but this did not interact with treatment allocation (P = .25 and P = .55, respectively). Participants were slightly younger than nonparticipants (median baseline age: 24 vs 27 y, P = .03). No other significant differences were observed between participants and nonparticipants. Participants at 10 years had an annual income from 9-10 years postrandomization which was 1700 euro larger than nonparticipants, although not significant (P = .06). After 10 years, a total of 29 participants were deceased-14 (5.1%) in the OPUS group and 15 (5.5%) in the TAU group, P = .83. These figures differ from those in the flow diagram, since those who were deceased but were not interviewed at the previous assessment point are not shown in the flow diagram.
Primary Outcomes: Data From Interviews
The courses of illness in the 2 intervention groups were firstly examined for differential time development by looking at time × intervention interaction effects from the repeated measures linear mixed models. These failed to reach significance for the psychotic dimension (P = .06), disorganized symptoms (P = .34), GAF symptom scores (P = .17), and GAF function scores (P = .17) but were significant for the negative dimension (P < .001). Table 2 presents observed means and SDs as well as estimated mean differences and P values of differences from the linear mixed models at 2-, 5-, and 10-year followups for outcomes assessed through interviews. The estimated mean differences and P values are thus intention to treat and account for missing data as described previously. After 10 years, there were no significant differences between the 2 groups. A graphical illustration of these 5 scales is given in figure 2 as estimated marginal means.
The proportion of people who, at the 10-year followup, had experienced suicidal ideation within the preceding 2 years was similar in OPUS (39.4%) and in TAU (37.9%), P = .77, as estimated using multiple imputations to account for missing follow-up data. The multiply-imputed proportions using antipsychotic medication were also similar, at 57.2% in OPUS and 60.2% in TAU, P = .53. the original group still alive and living in Denmark. The development in mean number of days in supported housing from 1 year after inclusion until 10 years after inclusion is different between the 2 groups in favor of OPUS (P < .001). Most people had no days in supported housing and a few people spent the entire year in supported housing. For this reason, CIs and P values were estimated using bootstrapping and permutation, respectively. Analyses of individual time points are shown in figure 3 , and it revealed that this difference is present for the first 6 years (P < .01), whereas there are no significant differences from 7 (P = .07) to 10 years (P > .10). Similarly, there were significant differences over time between the 2 interventions regarding the percentage having spent at least 1 day in supported housing, although the time × intervention interaction term was not significant (P = .08). Significantly more participants in OPUS than in TAU had spent at least 1 day in a homeless shelter at both the 2-year (P = .04) and the 10-year follow-up (P = .02). In absolute figures, however, the difference was of the magnitude 3 or 4 participants. Over the 10-year period, the 2 intervention groups developed significantly differently in favor of OPUS with regards to psychiatric bed days (P = .04), but P values were only significant for the first 3 years. Participants receiving TAU had higher risks of not receiving any outpatient treatment at the 2-year follow-up study, but not at the later follow-up studies. TAU and OPUS did not differ regarding treatment at psychiatric emergency rooms. There was no evidence of a time × intervention interaction effect regarding the number of annual days on sick leave (P = .13) or annual income (P = .98). There were no differences over time regarding having children, living with a partner, receiving early retirement benefits, or working or being under education.
Secondary Outcomes: Data From Registers
There was a marginally significant (P = .04) tendency toward people in the OPUS group being more likely to live alone (or alone with children) than people in the TAU group in the 2-year follow-up study, but not at the 5-year follow-up study. In the 10-year follow-up study, the tendency seemed to be reversed (P = .09), and so we regard this as coincidental. Note: Observed means and SD, along with estimated mean differences and P values obtained from linear mixed models adjusted for baseline values, center, age at inclusion, GAF scores, and diagnosis of substance use disorder at baseline. Time × intervention interaction terms: P = .06 (psychotic dimension), P < .001 (negative dimension), P = .34 (disorganized dimension), P = .17 (GAF Symptoms and GAF Function). GAF, Global Assessment of Functioning; TAU, treatment as usual. 
Ten-Year Follow-up of the OPUS Trial
Discussion
While significant time × intervention interaction effects were observed for a number of outcomes, these appeared to be driven by differences earlier on in the follow-up period. However, despite the experimental intervention ceasing after 2 years, there were still significant differences between OPUS and TAU groups regarding the number of days spent in supported housing 6 years after randomization. The proportion spending at least 1 day in supported housing was, however, rather low in both groups. Both groups had improved on several outcomes: less psychiatric services, supported housing and homeless shelters, and more frequently living with a partner. Conversely, after 10 years, both groups tended to have a reduced ability to work or study and increased likelihood to receive early retirement. Previous follow-up studies of the OPUS trial have shown larger intervention effects than the present study. At the 2-year follow-up study (immediately after the interventions ended), the OPUS treatment was clinically and statistically superior to TAU regarding levels of psychotic and negative symptoms, comorbid substance use, adherence to treatment, and satisfaction with treatment. 16 At the 5-year follow-up, 3 years after the intervention ended, the effects on interviewer-assessed outcomes were not significant, but significant effects on register-based variables such as use of supported housing and possibly psychiatric hospitalization were observed. 11 More participants in OPUS than in TAU had spent at least a day in a homeless shelter. While this could be an adverse effect of the OPUS treatment, it should be noted that the difference is very small in absolute numbers (1 person in the TAU group vs 4 or 5 in the OPUS group). It is also worth noting that it is not known if the alternative to staying in a homeless shelter would have been living on the streets, in which case the difference would be in favor of the OPUS group.
The near-absence of long-term between-group differences does not necessarily indicate that OPUS is not efficient in the long run. All participants were transferred to what was then TAU after OPUS ended, which primarily consisted of community mental health centers. In this study, patients from both intervention groups will thus, after the trial ended, have received 0-8 years of treatment in community mental health centers. They may also have received various degrees of inpatient treatment. This might dilute the potential for OPUS treatment to influence long-term outcomes. It is also possible that the introduction of OPUS in the Danish treatment system inspired the TAU centers to adopt some of the OPUS elements. If this is the case, the near-absence of differential effects in this 10-year follow-up could be in part due to an increase in the efficacy of TAU. The original hope of the OPUS trial was that an intensive, integrated treatment in the very first phases of patients' psychotic illness would have a profound and lasting positive effect, altering the course of the illness by acting as a "driver's license" for psychotic illness. Long-term follow-up does not support this outcome goal. The near-absence of a long-term effect may be due to at least 3 factors: Firstly, OPUS includes compensatory and psychoeducative/training elements which interplay with each other. The compensatory elements include the assertive approach and practical support in solving everyday life problems, etc. One explanation for the lack of long-term effect could be that the compensatory elements in OPUS played a crucial role in serving as a necessary milieu for the psychoeducative/training elements to exert their effect; secondly, 2 years of OPUS intervention is not sufficient to achieve a sustained longterm improvement and the psychoeducative/training elements need longer time or booster session to have a long-lasting effect. Ongoing research is comparing 5 years of OPUS with 2 years of OPUS followed by 3 years of community mental health centers (TAU) 30 ; thirdly, OPUS participants were required to change case managers when shifting to TAU after 2 years, which requires building a working alliance with this new case manager; fourthly, the trial did not include an early detection component, as reflected in our relatively long duration of untreated psychosis. The clear effects of the OPUS intervention after 2 years probably indicate that this is not a crucial element in the short term; it is possible, however, that adding an early detection component might have made the effects of OPUS more durable. It is also unclear whether adding components such as supported employment might have made the effects more durable as well.
To our knowledge, this is the first published study of long-term effects of specialized early intervention services beyond 5 years. Consequently, we hope that our results will be corroborated in upcoming analyses of, eg, the Lambert Early Onset trial in the UK or the Prevention and Early Intervention Program for Psychoses in Canada.
Strengths and Weaknesses
The present investigation has a number of important strengths. We used blinded outcome assessors at the 5-and 10-year follow-up interviews to avoid the risk of obtaining biased results. Secondly, analyses at 10 years were conducted according to the intention-to-treat principle, analyzing all participants in their allocated groups, regardless of how much of the intervention they actually received. Neglect of this principle is known to produce biases that generally overestimate effect-sizes. Thirdly, even though 8 years had passed since the original trial ended, but we were still able to get a follow-up rate above 68% of those still alive and living in Denmark. We used appropriate statistical methods to handle missing data in the analyses.
There are potential limitations to our study. It is possible that we only got a selected sample of participants to attend this long-term follow-up study. To address this potential limitation, we used appropriate statistical methods to handle missing data. Participants in this follow-up study did better on baseline GAF and were younger than those who did not participate. Therefore, the participants in the 10-year follow-up may, as would be expected, be doing better than those not participating and the sample may be biased in this way. This is confirmed by the nearly significant higher income among the participants. Furthermore, the primary findings from the present investigation come from register-based analyses, which are not prone to this type of error, due to the complete follow-up on the entire intention-to-treat sample.
Another potential limitation is the representativeness and external validity of the sample. The OPUS trial had very high inclusion rates and is thus representative of the population of people with FEP at the time the trial was conducted. It is not possible, however, to know if a similar trial, started today and followed for 10 years, would find identical results. The population of people with incident schizophrenia could differ now from 10-15 years ago, eg, due to enhanced efforts into early detection or different practices regarding psychiatric admissions. It is also not clear if long-term effects as observed in Denmark will translate to other countries with differently constructed healthcare systems and social services. However, there may be reasons for optimism on this point, as a recent meta-analysis showed rather context-independent effects of early intervention programs.
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Conclusion
Most of the short-term effects of the OPUS intervention were no longer present 8 years after the intervention ended. However, although the difference between the interventions in the 10th year was not significant, the OPUS patients had a significantly better 10-year course with respect to using less supported housing than the standard intervention. The OPUS patients also used significantly fewer psychiatric bed days over the whole 10-year period although not significantly so at any individual time points. More OPUS patients used homeless shelters after 2 and 10 years, but very few people in the cohort (5 OPUS and 1 TAU in the 10th year) accessed these shelters at all. These results still favor OPUS over standard treatment. Thus, it could be prudent to investigate if the positive effects of OPUS can be extended, eg, by lengthening the duration of the intervention from 2 to 5 years. 
